Programmed cell death 1 ligand 1(PDL1, PD-L1)

Clinical trials for Programmed cell death 1 ligand 1(PDL1, PD-L1) explained in plain language.

Never miss a new study

Get alerted when new Programmed cell death 1 ligand 1(PDL1, PD-L1) trials appear

Sign up with your email to follow new studies for Programmed cell death 1 ligand 1(PDL1, PD-L1), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New drug combo targets tough cancers in early trial

Disease control Ongoing

This early-phase study tests a new drug called MK-2870, either alone or with the immunotherapy pembrolizumab, in Japanese patients with advanced solid tumors or a type of lung cancer. The main goal is to check the safety and side effects of these treatments. About 30 people will …

Matched conditions: PROGRAMMED CELL DEATH 1 LIGAND 1(PDL1, PD-L1)

Phase 1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control

Last updated Sep 04, 2026 00:00 UTC

Programmed cell death 1 ligand 1(PDL1, PD-L1)

Get alerted when new Programmed cell death 1 ligand 1(PDL1, PD-L1) trials appear

New drug combo targets tough cancers in early trial